A 12 months comparison of the efficacy and safety of formoterol 4.5 mcg as needed with terbutaline 0.5 mg as needed in patients with asthma not treated with IGCS.
Study identifier:SD-037-0716
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
A 12 months comparison of the efficacy and safety of formoterol 4.5 mcg as needed with terbutaline 0.5 mg as needed in patients with asthma not treated with IGCS.
Medical condition
asthma
Phase
Phase 3
Healthy volunteers
-
Study drug
-
Sex
-
Actual Enrollment
-
Study type
Interventional
Age
-
Date
Study Start Date: 01 Feb 2001
Primary Completion Date: -
Study Completion Date: -
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
